About
About Addiction Institute at Mt Sinai West
The Addiction Institute at Mount Sinai West is a hospital-affiliated addiction treatment program based at 1000 10th Avenue in Manhattan, anchored within the Mount Sinai Health System. The Institute provides medical detoxification and outpatient substance use care, and operates a SAMHSA-certified Opioid Treatment Program offering methadone, buprenorphine, and related medication management for individuals with opioid use disorder.
Accredited by the Joint Commission, the program serves a diverse adult population in New York City, including clients managing co-occurring mental health conditions and individuals who are Deaf or hard of hearing, with American Sign Language services available. As part of the Mount Sinai network, the Addiction Institute can coordinate with primary care, psychiatry, and inpatient hospital services when integrated care is needed, which is particularly valuable for clients whose substance use intersects with chronic medical or psychiatric conditions.
Clinical care emphasizes evidence-based counseling, individual and group therapy, and medication-assisted treatment, structured around an outpatient schedule that allows clients to maintain work, school, and family obligations. The Institute accepts Medicaid, Medicare, private insurance, state coverage, and self-pay, with sliding scale and financial assistance available for eligible clients.
For New Yorkers seeking hospital-affiliated outpatient addiction care backed by an academic medical center, the Addiction Institute at Mount Sinai West offers a long-established program with strong connections to the broader Mount Sinai system. Its Midtown West location is accessible by multiple subway and bus lines, supporting consistent attendance for clients citywide.
- 24/7 inpatient medical detox unit with round-the-clock physician supervision
- Joint Commission accreditation ensures high medical standards for withdrawal management
- OTP certification with comprehensive opioid treatment protocols including buprenorphine and naltrexone
- Integration with Mt Sinai Health System provides access to full medical resources during detox
- Specialized dual diagnosis capabilities for patients with co-occurring mental health disorders